Heart attack patients: can a common gout pill improve bypass recovery?

NCT ID NCT05726019

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether the anti-inflammatory drug colchicine can reduce complications like irregular heartbeat, heart sac inflammation, and heart damage after coronary artery bypass surgery. 100 patients who had a recent heart attack and needed bypass surgery were randomly assigned to receive colchicine or a placebo for 30 days after surgery. The goal was to see if colchicine could improve recovery and prevent common post-surgery problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Heart Institute - University of São Paulo

    São Paulo, São Paulo, 05403000, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.